Expert InterviewNVS
Slingshot members are talking to an expert! The topic is:
Discussing iptacopan and the results of the APPEAR-C3G study in patients with C3 Glomerulopathy
Executed on:Mar 5, 2024 4:00 PM EDT
Call Duration:30 minutes
Expert Profile
ExpertBlinded Expert
Institution: Montefiore
- Medical Director, Pediatric Nephrology at Montefiore Health System, Inc., Associate Professor of Pediatrics at the Albert Einstein College of Medicine & Visiting Assistant Professor at Rockefeller University
- Manages 80 IgAN and 45 pMN patients
- Involved in clinical and translational research studying factors leading to progression to end-stage kidney disease, including fibrosis and complement-mediated pathways in lupus nephritis. Clinical interests are polycystic kidney disease, lupus nephritis, genetic causes of stone disease, complement pathway defects, immune-mediated renal diseases and biomarkers of acute kidney injury with a research interest is in lupus nephritis.
Interview Goal
Discuss effiacy/safety of iptacopan and how it compares to existing treatment options